Nephros (NEPH) Current Assets (2010 - 2026)

Nephros has reported Current Assets for 17 years, with the latest figure at $13.6 million in Q2 2026.

• On a quarterly basis, Current Assets rose 41.95% year-over-year to $13.6 million in Q2 2026; TTM through Jun 2026 was $13.6 million, a 41.95% increase from a year earlier, with the FY2025 full-year figure at $11.2 million, up 35.25% from the prior year.
• Current Assets was $13.6 million for Q2 2026 at Nephros, up from $11.5 million in the prior quarter.
• The five-year high for Current Assets was $13.6 million in Q2 2026, with the low at $7.4 million in Q3 2024.
• Average Current Assets over 5 years is $9.5 million, with a median of $8.7 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Current Assets plunged 39.41% in 2022, then jumped 45.54% in 2025.
• Over 5 years, Current Assets stood at $8.3 million in 2022, then advanced by 1.74% to $8.4 million in 2023, then slipped by 1.27% to $8.3 million in 2024, then jumped by 35.25% to $11.2 million in 2025, then rose by 21.14% to $13.6 million in 2026.
• The last three Current Assets figures came in at $13.6 million (Q2 2026), $11.5 million (Q1 2026), and $11.2 million (Q4 2025), per Business Quant data.